Accelerate Diagnostics schedules call to review 2020 fourth quarter and full year results

Rhea-AI Summary

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) has scheduled a conference call for February 23, 2021, at 4:30 p.m. Eastern Time, to discuss the financial results for the fourth quarter and full year 2020. The call will provide insights into the company’s performance, focusing on their in vitro diagnostics solutions aimed at combating antibiotic resistance and sepsis. An audio webcast will be available at ir.axdx.com, and a replay will be accessible until May 24, 2021.

Positive

• The Accelerate Pheno® system automates sample preparation, providing results in about 7 hours.
• Recent studies show results 1 to 2 days faster than existing methods, improving antibiotic selection for patients.

Negative

• None.

TUCSON, Ariz., Feb. 1, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Tuesday, February 23, 2021, at 4:30 p.m. Eastern Time to review 2020 fourth quarter and full year financial results.

To listen to the audio webcast online, visit ir.axdx.com. A replay of the audio webcast will be available until May 24, 2021.

To listen by phone, dial +1.877.883.0383 and enter the conference ID: 9000762. International participants may dial +1.412.902.6506. Please dial in 10-15 minutes prior to the start of the conference.

A replay of the call will be available by telephone at +1.877.344.7529 (U.S.) or +1.412.317.0088 (International) using the replay code 10151395 until March 16, 2021.

About Accelerate Diagnostics, Inc.

Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for serious infections. The FDA-cleared system and kit fully automate sample preparation steps, enabling phenotypic antibiotic susceptibility results in about 7 hours directly from positive blood cultures. Recent external studies indicate the solution offers results 1 to 2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient's infection, days earlier.

The "ACCELERATE DIAGNOSTICS" and "ACCELERATE PHENO" and "ACCELERATE PHENOTEST" and diamond shaped logos and marks are registered trademarks of Accelerate Diagnostics, Inc.

For more information about the company, its products and technology, or recent publications, visit axdx.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/accelerate-diagnostics-schedules-call-to-review-2020-fourth-quarter-and-full-year-results-301218595.html

SOURCE Accelerate Diagnostics, Inc.

FAQ

When is the Accelerate Diagnostics conference call for Q4 2020 results?

The conference call is scheduled for February 23, 2021, at 4:30 p.m. Eastern Time.

How can I listen to the Accelerate Diagnostics conference call?

You can listen live at ir.axdx.com or by phone at +1.877.883.0383 with conference ID 9000762.

Is there a playback option for the Accelerate Diagnostics conference call?

Yes, a replay will be available until March 16, 2021, at +1.877.344.7529.

What technologies does Accelerate Diagnostics use to address antibiotic resistance?

The company uses the Accelerate Pheno® system and Accelerate PhenoTest® BC kit for rapid antibiotic susceptibility testing.

What advantages does the Accelerate Pheno® system offer?

It offers phenotypic antibiotic susceptibility results 1 to 2 days faster than traditional methods.